Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2009 Jun 8.
Published in final edited form as: Biochem Biophys Res Commun. 2007 Dec 26;366(4):988–993. doi: 10.1016/j.bbrc.2007.12.058

Allosterically Coupled Calcium and Magnesium Binding Sites are Unmasked by Ryanodine Receptor Chimeras

Andrew A Voss a,c, Paul D Allen b, Isaac N Pessah a, Claudio F Perez b
PMCID: PMC2693413  NIHMSID: NIHMS38729  PMID: 18096513

Abstract

We studied cation regulation of wild type ryanodine receptor type 1 (WTRyR1), type 3 (WTRyR3) and RyR3/RyR1 chimeras (Ch) expressed in 1B5 dyspedic myotubes. Using [3H]ryanodine binding to sarcoplasmic reticulum (SR) membranes, Ca2+ titrations with WTRyR3 and three chimeras show biphasic activation that is allosterically coupled to attenuated inhibition relative to WTRyR1. Chimeras show biphasic Mg2+ inhibition profiles at 3 and 10μM Ca2+, no observable inhibition at 20μM Ca2+ and monophasic inhibition at 100μM Ca2+. Ca2+ imaging of intact myotubes expressing Ch-4 exhibit caffeine-induced Ca2+ transients with inhibition kinetics that are significantly slower than those expressing WTRyR1 or WTRyR3. Four new aspects of RyR regulation are evident: 1) high affinity (H) activation and low affinity (L) inhibition sites are allosterically coupled, 2) Ca2+ facilitates removal of the inherent Mg2+ block, 3) WTRyR3 exhibits reduced cooperativity between H activation sites when compared to WTRyR1, and 4) uncoupling of these sites in Ch-4 results in decreased rates of inactivation of caffeine-induced Ca transients.

Keywords: ryanodine receptors, calcium-induced calcium release, channel regulation


Three isoforms of wild type ryanodine receptors (WTRyR1, 2 and 3) are expressed in specialized regions of endoplasmic/sarcoplasmic reticulum (ER/SR) in most mammalian cells where they function as Ca2+ release channels that produce local and global Ca2+ signals [1] and 2]. Fluctuating physiological cation concentrations, especially Ca2+ and Mg2+, tightly regulate all three WTRyR isoforms [3], [4], [5], [6], [7], [8] and [9]. Cytoplasmic Ca2+ ranging from nM to μM enhances the open probability of WTRyRs, whereas >100 μM Ca2+ or Mg2+ depresses channel activity [5], [10] and [11]. The “bell shaped” regulation of WTRyR by Ca2+ is thought to be responsible for physiological and pathophysiological Ca2+-induced Ca2+ release (CICR) phenomena observed in many cell types, including muscle and neurons [1], [2], [12], [13] and [14].

WTRyR isoforms preferentially bind the plant alkaloid ryanodine with nM affinity when in the open state [3], [6], and [7]. Ca2+ and Mg2+ titrations in [3H]ryanodine binding and Ca2+ release experiments have revealed Hill coefficients >1, indicating multiple, coordinated regulation of CICR channels by multiple cation binding sites [15]. Mg2+ inhibition studied with channels reconstituted in lipid bilayer membranes [16] and Ca2+ release from SR membrane vesicles [4] and [11] suggest dual mechanisms of Mg2+ inhibition through competition with Ca2+ for high affinity (H) activation sites and binding at low affinity (L) cation inhibition sites. At physiological concentrations, free Mg2+ (1–2mM) is likely to occupy both H and L sites, providing a basal level of WTRyR inhibition that must be overcome for EC-coupling to occur [17] and [18]. Studies have suggested that the physical coupling between WTRyR and the dihydropyridine receptor (DHPR) may remove the Mg2+ block during EC-coupling [18]; whereas, other authors have suggested oxidation of WTRyR sulfhydryl groups may override Mg2+ inhibition [19]. Functional overlap in Ca2+ and Mg2+ interactions at H and L regulation sites have confounded cation regulation studies of WTRyR1 and resulted in conclusions partially derived from extrapolation. A system that permits more direct analysis of cytoplasmic Ca2+ and Mg2+ regulation would greatly facilitate mechanistic interpretations about RyR cation regulation in health and disease.

RyR3/RyR1 chimeras were designed to identify regions of WTRyR1 directly associated with the DHPR during EC-coupling [20] and [21]. In this report, [3H]ryanodine binding experiments on WTRyR1, WTRyR3, and a subset of these chimeras (Ch-4: WTRyR1 1681-3770; Ch-17: 1681–2217; Ch-21: 1924–2446) reveal a biphasic cytoplasmic Ca2+ activation profile, suggesting variable cooperativity between H activation sites, revealing coupled but separated interactions at H activation and L inhibition sites. This study provides direct insight into Ca2+ and Mg2+ regulation, suggests new aspects of WTRyR function, and establishes the chimeras as models for future studies of WTRyRs and cation regulation.

Materials and Methods

Chimeric RyR1/RyR3 constructs

Specific primers were designed for PCR amplification of the selected fragments using WTRyR1 as a template. Amplified fragments from WTRyR1 encoding aa 1681–2217 (Ch-17), 1924–2446 (Ch-21) and 1681–3770 (Ch-4) were inserted, in frame, into the endogenous restriction site(s) of HSV-RyR3 plasmid as described previously [20]. All chimeric constructs were cloned into the HSV-1 amplicon vector and packaged using a helper virus-free packaging system [22].

Cell culture, infection and membrane preparation

1B5 myoblasts were cultured and differentiated into myotubes as described previously [20] and [23]. Plates with differentiated myotubes were infected with virion containing wild type and RyR1/RyR3 chimeric cDNA for 2 h and membrane extracts were prepared 36 h after infection. Myotubes were homogenized and membrane fractions obtained by differential centrifugation as described previously [24].

[3H]Ryanodine binding assay

High affinity binding of [3H]ryanodine ([3H]Ry; 56 Ci/mmol; New England Nuclear, Boston, MA) to membranes (10–50μg/ml protein) was performed in the presence of 250mM KCl, 20mM Hepes pH 7.4 and 5nM [3H]Ry [6]. Free Ca2+ and Mg2+ concentrations buffered with EGTA were determined using the Bound And Determined software [25]. The binding reaction was equilibrated at 37 °C for 3h. Non-specific binding was assessed in the presence of 5μM unlabeled ryanodine. Bound ligand was separated from free by filtration through Whatman GF/B glass fiber filters using a Brandel cell harvester (Gaithersburg, MD), washed with ice-cold buffer, placed into 5 ml scintillation cocktail (ScintiVerse; Fisher Scientific) and radioactivity counted.

Equations for binding analysis

Curve fitting was generated by Microcal Origin® Version 6.0 using the equations:

Activation:

a)y=(Bmax)(xn)kn+xnb)y=(Bmax1)(xn1)k1n1+xn1+(Bmax2)(xn2)k2n2+xn2

where, Bmax = maximum bound, k = EC50 and n = Hill coefficient

Inhibition:

c)y=A1A21+(xxo)p+A2d)y=A2+(A1A2)f1+10(xlogxo1)+(A1A2)(1f)1+10(xlogxo2)

where A1 = top asymptote, A2 = bottom asymptote, xo = IC50, f = fraction and p = power

Ca2+ imaging

Calcium imaging was performed during the stable phase of transduced protein expression in the myotubes 36–48h post-infection as previously described [20]. Ca2+ release was induced with 20s perfusion of 20mM caffeine. Monophasic exponential decay curves were fitted with GraphPad Prism® Version 4.0 according to following function: y=Span · e(k·X) + Plateau were k= rate constant.

Results and Discussion

To examine cation regulation, both WTRyRs and RyR3/RyR1 chimeras were expressed in dyspedic 1B5 myotubes, a cell line void of all WTRyR isoforms, but containing the accessory proteins necessary for normal WTRyR function [26]. Regulation of WTRyRs and chimeras in membrane fractions was assessed using [3H]Ry binding to probe cation regulation of channel conformation permitting direct analysis of cytoplasmic Ca2+ and Mg2+ regulation of RyR conformation [6] without confounding influences of varying luminal Ca2+ [27].

Ca2+ regulation

Ca2+ activation of WTRyR1 and WTRyR3 determined by [3H]Ry binding (Fig. 1A) indicated monophasic activation of WTRyR1 (EC50=0.54±0.05μM) and biphasic activation of WTRyR3 (EC50(1) and EC50(2)=0.36±0.06μM and 20.0±5.78μM) with a plateau from 4 – 8 μM (inset). Similar analyses of Ch-21, -17 and -4 revealed accentuated biphasic Ca2+ responses, with plateaus of 20–100μM, 10–100μM and 3–100μM, respectively (Fig. 1B). Ch-21, −17 and −4 exhibited EC50(1) values of 0.90±0.19μM, 0.39±0.09μM and 0.18±0.03μM, and EC50(2) values of 397±190 μM, 510±174μM, and 761±192μM, respectively (Table 1).

Fig. 1.

Fig. 1

Ca2+ regulation of wild type and chimeric RyR3/RyR1 expressed in dyspedic 1B5 myotubes, determined by [3H]Ry binding (see METHODS). (A) Activation of RyR1 (Inline graphic) and RyR3 (Inline graphic) curve fit with Hill and biphasic Hill equations, respectively. (B) Activation of Ch-4 (Inline graphic), Ch-17 (---◇---) and Ch-21 (—▽—) curve fit with a biphasic Hill equation. (C) Inhibition of RyR1 (Inline graphic) and RyR3 (Inline graphic) curve fit with a monophasic equation. (D) Inhibition of Ch-4 (Inline graphic), Ch-17 (---◇---) and Ch-21 (—▽—) with a biphasic equation. Data points are the mean values, error bars are ± standard deviations. Activation profiles for WTRyR1, WTRyR3 and Ch-4 were the combined result of 2–4 experiments performed in duplicate or triplicate from multiple 1B5 membrane preparations.

Table 1.

Curve fit statistics for [3H]Ry binding analyses of Ca2+ activation

Construct EC50(1) (μM ) EC50(2) (μM ) Hill Coeff. 1 Hill Coeff. 2 r2
WTRyR1 0.54 ± 0.05 N/A 2.42 ± 0.48 N/A 0.982
WTRyR3 0.36 ± 0.06 20.0 ± 5.78 3.26 ± 1.75 1.29 ± 0.40 0.985
Ch-4 0.18 ± 0.03 761 ± 192 1.04 ± 0.17 1.78 ± 0.65 0.986
Ch-17 0.39 ± 0.09 510 ± 174 1.20 ± 0.33 3.08 ± 2.90 0.961
Ch-21 0.90 ± 0.19 397 ± 190 1.03 ± 0.19 3.06 ± 4.32 0.985

The biphasic profiles suggest WTRyR3 and chimeras possess reduced cooperativity between H activation sites compared to WTRyR1. The Ca2+ dependence of WTRyR3 has been previously published based on immunoprecipitated protein and the resulting data fitted using a single-site model indicating monophasic activation of WTRyR3 by Ca2+ [28] and [29]. Two significant methodological differences distinguish the present study. First, the use of SR membranes from WTRyR3-expressing 1B5 myotubes preserves known interactions with lumenal proteins such as calsequestrin [26] that are known to contribute to cation regulation of WTRyR1 and WTRyR2 [27] and [30]. Second, the extremely broad titrations in previous studies with immunopurified WTRyR3 consisted of 2–4 data points covering several log range of Ca2+ concentrations and would have missed the biphasic activation of WTRyR3 by Ca2+ if present after immunopurification. The present study is the first report of a distinctly biphasic activation for WTRyR3 and may result from an altered conformation relative to WTRyR1 that is exaggerated in the chimeras. A slight variation in protein conformation would explain the deviation in chimeric Ca2+ activation from that of WTRyR1 and 3, an unpredictable response based on primary sequence alone. It is also noteworthy that previously published whole cell Ca2+ imaging experiments indicate these chimeras expressed in 1B5 cells are functional, with all three constructs exhibiting calcium-induced Ca2+ release (CICR) and Ch-4 and −21 additionally engaging skeletal-type EC-coupling [20]. Interestingly, a recent [3H]Ry-binding study with membranes isolated from rat ventricular muscle showed a similar biphasic Ca2+ activation curve for RyR2, which was reverted to a monophasic binding profile in the presence of Mg2+ [31]. Collectively these results support a mechanism by which coordinated Ca2+ activation sites regulate RyR conformations that bind ryanodine with high affinity.

[3H]Ry binding analysis of Ca2+ inhibition through L sites revealed an attenuated response that correlates to H site cooperativity (Fig. 1C & D). Compared to WTRyR1, multiple aspects of Ca2+inhibition were shifted in WTRyR3 and chimeric constructs. First, the onset of inhibition is attenuated in WTRyR3 and Ch-21 to ~ 1mM and in Ch-17 and −4 to ~3–4mM vs. WTRyR1 at 100μM. Additionally, the extent of inhibition observed in the chimeras is shifted, where Ch-21, −17, and −4 were respectively 84%, 60% and 39% of the near complete inhibition observed in WTRyR1 and WTRyR3. Finally, as summarized in Table 2, the IC50 values suggested attenuated inhibition compared to WTRyR1 (0.84±0.08mM) in WTRyR3 (3.08±0.88mM), Ch-21 (4.11±0.27 mM), Ch-17 (5.09±4.13mM) and Ch-4 (5.86±1.18mM) (Table 2). The extent of attenuated Ca2+ inhibition through L sites appeared related to H site cooperativity, in which channels with the greatest reduction in H site cooperativity exhibit the largest attenuation in L site mediated inhibition. These data strongly suggests H and L sites are allosterically coupled.

Table 2.

Curve fit statistics for [3H]Ry binding analyses of Ca2+ inhibition

Construct IC50 (mM) r2
WTRyR1 0.84 ± 0.08 0.997
WTRyR3 3.08 ± 0.88 0.999
Ch-4 5.86 ± 1.18 0.985
Ch-17 5.09 ± 4.13 0.999
Ch-21 4.11 ± 0.27 0.994

The observations presented heretofore illustrate a model of RyR regulation by Ca2+ in which the binding of at least one H site by Ca2+ induced a plateau in [3H]Ry binding. This plateau was undetected in WTRyR1 due to cooperative binding of Ca2+ to at least one additional H site, but was observed in WTRyR3 and further exacerbated in chimeras where there was a reduction in cooperativity between H sites. Binding of Ca2+ to the additional H site(s) induced a conformational transition to a state of maximal ryanodine binding. Further increases of Ca2+ occupied L sites and decreased [3H]Ry binding. This data indicates H and L sites are allosterically coupled, as the onset of L site mediated inhibition did not occur until complete H site occupation, and complete inhibition through L sites required near-complete cooperativity between H sites.

Mg2+ inhibition

In light of Ca2+ regulation through coupled but separated H and L sites, we examined with [3H]Ry the role of Mg2+ in Ch-4 cation regulation (Fig. 2; Table 3), with curve statistics summarized in Table 3. In the presence of 3 and 10 μM Ca2+, Mg2+ produced biphasic responses with IC50(1) values of 0.40±0.13mM and 0.64±0.09mM, respectively. The IC50(2) values for Mg2+ at 3 and 10μM Ca2+ were 5.71±0.31mM and 4.18±0.16mM, respectively. At 100μM Ca2+, the first phase of Mg2+ inhibition was not detected and only an incomplete (~40% of maximum), monophasic inhibition (IC50=4.06±0.40mM) was observed. The biphasic Mg2+ profiles at 3 and 10μM Ca2+ likely represent competition with Ca2+ for H sites in the first phase and binding to L sites in the second. Competition by Mg2+ for H sites is supported by a shifting first phase for Mg2+ inhibition at 3 and 10μM Ca2+ that is not observed at 100μM Ca2+. Binding of Mg2+ to L sites is described by a monophasic inhibition at 100μM Ca2+ (IC50=4–6mM), a range that corresponds to the observed Ca2+ inhibition through L sites (5.86+ 1.18mM) in Fig. 1D. Theses results provide more direct biochemical evidence in support of the dual mechanism of Mg2+ inhibition originally proposed by Meissner and Laver based on experiments with WTRyR [4], [16] and [32].

Fig. 2.

Fig. 2

Mg2+ inhibition at variable Ca2+ of Ch-4 expressed in dyspedic 1B5 myotubes, determined by 3H-ryanodine binding (see METHODS). In the presence of 3 (Inline graphic) and 10 μM (···□···) Ca2+ curve fit with a biphasic equation. In the presence of 20μM Ca2+ (—▲—) fit linearly (m = −0.0032±0.0029 and b = 0.611±0.015) and at 100μM Ca2+ (---◆---) curve fit with a monophasic equation. Data points are the mean value for at least two experiments, error bars are ± standard deviations.

Table 3.

Curve fit statistics for [3H]Ry binding analyses of Ch-4 Mg2+ inhibition at variable Ca2+

[Ca2+] IC50(1) (mM) IC50(2) (mM) r2
3 μM 0.40 ± 0.13 5.71 ± 0.31 0.964
10 μM 0.64 ± 0.09 4.18 ± 0.16 0.998
20 μM No Inhibition
100 μM 4.06 ± 0.40 N/A 0.881

An intriguing finding was that Mg2+ titrations in the presence of 20μM Ca2+ produced no observable inhibition in [3H]Ry binding experiments. Loss of Mg2+ inhibition would be possible through competition at H sites and a conformational state at the Ca2+ biphasic plateau, which reduces the affinity of Mg2+ at L sites relative to conformations at low (3 and 10μM) and high (100μM) Ca2+. Alternatively, Mg2+ binding could impart an activating effect on H sites, as suggested for rat RyR2 [31]. This further supports allosteric coupling between H and L sites and suggests Ca2+ may contribute along with DHPR [18] and oxidation [19] to relieving the inherent physiological block provided by Mg2+.

Physiological relevance of the observations presented in this work depend on the idea that chimeric characteristics unmasked by the reduced H site cooperativity are inherent to WTRyR, but are difficult to observe in wild type (especially WTRyR1) due to overlapping interactions at H and L sites. For WTRyR3 however, the present results would predict unique functional effects at Ca2+ concentrations corresponding to the activation plateau (4–8μM) shown in Fig. 1A. Indeed, at 5–10μM Ca2+, WTRyR3 was shown to exhibit increased subconductance behavior relative to WTRyR1 [28] and [33]. This correlation is additionally supported by increased subconductance behavior of brain WTRyRs at specific Ca2+ and ATP concentrations [34].

Ca2+ release from SR stores

To extend the [3H]Ry binding results, we examined the effect of altered Ch-4 cation regulation on Ca2+ release in transduced 1B5 myotubes. In these cells, transduced Ch-4 was shown to engage skeletal-type EC-coupling and respond to caffeine stimulation [20] and [24]. We therefore compared the kinetics associated with caffeine-induced Ca2+ release from myotubes expressing WTRyR1, WTRyR3, and Ch-4. Since Ch-4 cation inhibition is attenuated at basal levels of intracellular Ca2+ or Mg2+ due to incomplete occupation of H sites, we predict a prolonged Ca2+ response following a caffeine-induced Ca2+ transient for myotubes expressing Ch-4 compared to those expressing WTRyR1 or WTRyR3. Figure 3 shows the average Ca2+ transients induced by 20 mM caffeine in 1B5 myotubes expressing each construct and loaded with Fluo-4. Upon caffeine application a fast phase of Ca2+ release and subsequent slower phase of cytoplasmic Ca2+ removal was followed by a fast Ca2+ removal phase after caffeine withdrawal. Whereas all constructs showed seemingly identical activation kinetics for caffeine-induced Ca2+ release, Ch-4-expressing cells presented a noticeable reduction in the slow Ca2+ removal phase and hence prolonged Ca2+ response when compared to cells expressing either WTRyR1 or WTRyR3. Analysis of the slow Ca2+ removal phase using a monophasic exponential decay reveals that the rate constant (k) for Ch-4 expressing myotubes is nearly 2.5 fold slower than those measured for WTRyR1 or WTRyR3 myotubes (Fig. 3). Since saturating concentrations of caffeine were used to induce Ca2+ release, the differences in k values observed in this study were most likely associated to the differences in Ca2+ and Mg2+ regulation of Ch-4 and not to potential differences in sensitivity to the agonist between the three constructs.

Fig 3.

Fig 3

Caffeine-induced Ca2+ release kinetics of 1B5 myotubes expressing Ch-4, WTRyR1 or WTRyR3. Average Ca2+ transients, normalized by the peak amplitude, are presented for each construct (Mean±SE). For clarity trend line for Ch-4 is displayed without SE. Rate constant were calculated using only the decay portion of each Ca2+ transient.

Conclusion

The results with RyR1/RyR3 chimeras presented here provide novel insights into the allosteric mechanisms by which Ca2+ and Mg2+ regulate RyRs, especially interactions between H and L cation binding sites. This allosteric coupling underscores the importance of considering the contribution of Mg2+ in addition to Ca2+ when assessing RyR function, as physiological levels of Mg2+ likely occupy WTRyR L sites and may influence Ca2+ activation through H sites. Furthermore, these results suggest that observed differences between WTRyRs and/or chimeric constructs should be interpreted with awareness of specific channel responsiveness to and the concentrations of Ca2+ and Mg2+. This is made apparent by variable responses to the same cation concentrations among wild type and chimeric RyRs. The contribution of RyR effectors such as FKBP, ATP, DHPR and oxidation in the context of the cation allosteric regulation presented here is yet to be determined. Additionally, the association of subconductance behavior to Ca2+ concentrations in the activation plateau needs to be further examined. This work provides new insights into WTRyR regulation and function, and establishes RyR chimeras, particularly Ch-4, as a model for future studies of RyR cation regulation and subconductance behavior.

Acknowledgments

This work was supported by 1RO1 AR43140-10A1 (PDA and INP) and Training Grant T20 ES07059 (AAV) from the National Institutes of Health.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Berridge MJ. Calcium microdomains: organization and function. Cell Calcium. 2006;40:405–12. doi: 10.1016/j.ceca.2006.09.002. [DOI] [PubMed] [Google Scholar]
  • 2.Zalk R, Lehnart SE, Marks AR. Modulation of the ryanodine receptor and intracellular calcium.m. Annu Rev Biochem. 2007;76:367–85. doi: 10.1146/annurev.biochem.76.053105.094237. [DOI] [PubMed] [Google Scholar]
  • 3.Pessah IN, Waterhouse AL, Casida JE. The calcium-ryanodine receptor complex of skeletal and cardiac muscle. Biochem Biophys Res Commun. 1985;128:449–56. doi: 10.1016/0006-291x(85)91699-7. [DOI] [PubMed] [Google Scholar]
  • 4.Meissner G, Darling E, Eveleth J. Kinetics of rapid Ca2+ release by sarcoplasmic reticulum. Effects of Ca2+, Mg2+, and adenine nucleotides. Biochemistry. 1986;25:236–44. doi: 10.1021/bi00349a033. [DOI] [PubMed] [Google Scholar]
  • 5.Smith JS, Coronado R, Meissner G. Single channel measurements of the calcium release channel from skeletal muscle sarcoplasmic reticulum. Activation by Ca2+ and ATP and modulation by Mg2+ J Gen Physiol. 1986;88:573–88. doi: 10.1085/jgp.88.5.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Pessah IN, Stambuk RA, Casida JE. Ca2+-activated ryanodine binding: mechanisms of sensitivity and intensity modulation by Mg2+, caffeine, and adenine nucleotides. Mol Pharmacol. 1987;31:232–8. [PubMed] [Google Scholar]
  • 7.Chu A, Diaz-Munoz M, Hawkes MJ, Brush K, Hamilton SL. Ryanodine as a probe for the functional state of the skeletal muscle sarcoplasmic reticulum calcium release channel. Mol Pharmacol. 1990;37:735–41. [PubMed] [Google Scholar]
  • 8.Murayama T, Ogawa Y. Purification and characterization of two ryanodine-binding protein isoforms from sarcoplasmic reticulum of bullfrog skeletal muscle. J Biochem (Tokyo) 1992;112:514–22. doi: 10.1093/oxfordjournals.jbchem.a123931. [DOI] [PubMed] [Google Scholar]
  • 9.Murayama T, Ogawa Y. Similar Ca2+ dependences of [3H]ryanodine binding to alpha-and beta-ryanodine receptors purified from bullfrog skeletal muscle in an isotonic medium. FEBS Lett. 1996;380:267–71. doi: 10.1016/0014-5793(96)00053-1. [DOI] [PubMed] [Google Scholar]
  • 10.Bezprozvanny I, Watras J, Ehrlich BE. Bell-shaped calcium-response curves of Ins(1,4,5)P3- and calcium-gated channels from endoplasmic reticulum of cerebellum. Nature. 1991;351:751–4. doi: 10.1038/351751a0. [DOI] [PubMed] [Google Scholar]
  • 11.Zimanyi I, Pessah IN. Comparison of [3H]ryanodine receptors and Ca++ release from rat cardiac and rabbit skeletal muscle sarcoplasmic reticulum. J Pharmacol Exp Ther. 1991;256:938–46. [PubMed] [Google Scholar]
  • 12.Thibault O, Gant JC, Landfield PW. Expansion of the calcium hypothesis of brain aging and Alzheimer’s disease: minding the store. Aging Cell. 2007;6:307–17. doi: 10.1111/j.1474-9726.2007.00295.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Sobie EA, Song LS, Lederer WJ. Restitution of Ca(2+) release and vulnerability to arrhythmias. J Cardiovasc Electrophysiol. 2006;17(Suppl 1):S64–S70. doi: 10.1111/j.1540-8167.2006.00385.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Rossi AE, Dirksen RT. Sarcoplasmic reticulum: the dynamic calcium governor of muscle. Muscle Nerve. 2006;33:715–31. doi: 10.1002/mus.20512. [DOI] [PubMed] [Google Scholar]
  • 15.Meissner G. Regulation of mammalian ryanodine receptors. Front Biosci. 2002;7:d2072–80. doi: 10.2741/A899. [DOI] [PubMed] [Google Scholar]
  • 16.Laver DR, Baynes TM, Dulhunty AF. Magnesium inhibition of ryanodine-receptor calcium channels: evidence for two independent mechanisms. J Membr Biol. 1997;156:213–29. doi: 10.1007/s002329900202. [DOI] [PubMed] [Google Scholar]
  • 17.Donoso P, Hidalgo C. pH-sensitive calcium release in triads from frog skeletal muscle. Rapid filtration studies. J Biol Chem. 1993;268:25432–8. [PubMed] [Google Scholar]
  • 18.Lamb GD, Stephenson DG. Effect of Mg2+ on the control of Ca2+ release in skeletal muscle fibres of the toad. J Physiol. 1991;434:507–28. doi: 10.1113/jphysiol.1991.sp018483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Donoso P, Aracena P, Hidalgo C. Sulfhydryl oxidation overrides Mg(2+) inhibition of calcium-induced calcium release in skeletal muscle triads. Biophys J. 2000;79:279–86. doi: 10.1016/S0006-3495(00)76290-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Perez CF, Voss A, Pessah IN, Allen PD. RyR1/RyR3 Chimeras Reveal that Multiple Domains of RyR1 Are Involved in Skeletal-Type E-C Coupling. Biophys J. 2003;84:2655–63. doi: 10.1016/S0006-3495(03)75071-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Sheridan DC, Takekura H, Franzini-Armstrong C, Beam KG, Allen PD, Perez CF. Bidirectional signaling between calcium channels of skeletal muscle requires multiple direct and indirect interactions. Proc Natl Acad Sci U S A. 2006;103:19760–5. doi: 10.1073/pnas.0609473103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Wang Y, Fraefel C, Protasi F, Moore RA, Fessenden JD, Pessah IN, DiFrancesco A, Breakefield X, Allen PD. HSV-1 amplicon vectors are a highly efficient gene delivery system for skeletal muscle myoblasts and myotubes. Am J Physiol Cell Physiol. 2000;278:C619–26. doi: 10.1152/ajpcell.2000.278.3.C619. [DOI] [PubMed] [Google Scholar]
  • 23.Protasi F, Paolini C, Nakai J, Beam KG, Franzini-Armstrong C, Allen PD. Multiple regions of RyR1 mediate functional and structural interactions with alpha(1S)-dihydropyridine receptors in skeletal muscle. Biophys J. 2002;83:3230–44. doi: 10.1016/S0006-3495(02)75325-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Perez CF, Mukherjee S, Allen PD. Amino acids 1–1,680 of ryanodine receptor type 1 hold critical determinants of skeletal type for excitation-contraction coupling. Role of divergence domain D2. J Biol Chem. 2003;278:39644–52. doi: 10.1074/jbc.M305160200. [DOI] [PubMed] [Google Scholar]
  • 25.Brooks SP, Storey KB. Bound and determined: a computer program for making buffers of defined ion concentrations. Anal Biochem. 1992;201:119–26. doi: 10.1016/0003-2697(92)90183-8. [DOI] [PubMed] [Google Scholar]
  • 26.Moore RA, Nguyen H, Galceran J, Pessah IN, Allen PD. A transgenic myogenic cell line lacking ryanodine receptor protein for homologous expression studies: reconstitution of Ry1R protein and function. J Cell Biol. 1998;140:843–51. doi: 10.1083/jcb.140.4.843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Laver DR. Ca2+ stores regulate ryanodine receptor Ca2+ release channels via luminal and cytosolic Ca2+ sites. Clin Exp Pharmacol Physiol. 2007;34:889–96. doi: 10.1111/j.1440-1681.2007.04708.x. [DOI] [PubMed] [Google Scholar]
  • 28.Murayama T, Oba T, Katayama E, Oyamada H, Oguchi K, Kobayashi M, Otsuka K, Ogawa Y. Further characterization of the type 3 ryanodine receptor (RyR3) purified from rabbit diaphragm. J Biol Chem. 1999;274:17297–308. doi: 10.1074/jbc.274.24.17297. [DOI] [PubMed] [Google Scholar]
  • 29.Murayama T, Ogawa Y. Characterization of type 3 ryanodine receptor (RyR3) of sarcoplasmic reticulum from rabbit skeletal muscles. J Biol Chem. 1997;272:24030–7. doi: 10.1074/jbc.272.38.24030. [DOI] [PubMed] [Google Scholar]
  • 30.Gyorke S, Terentyev D. Modulation of ryanodine receptor by luminal calcium and accessory proteins in health and cardiac disease. Cardiovasc Res. 2007 doi: 10.1093/cvr/cvm038. [DOI] [PubMed] [Google Scholar]
  • 31.Chugun A, Sato O, Takeshima H, Ogawa Y. Mg2+ activates the ryanodine receptor type 2 (RyR2) at intermediate Ca2+ concentrations. Am J Physiol Cell Physiol. 2007;292:C535–44. doi: 10.1152/ajpcell.00275.2006. [DOI] [PubMed] [Google Scholar]
  • 32.Meissner G. Ryanodine receptor/Ca2+ release channels and their regulation by endogenous effectors. Annu Rev Physiol. 1994;56:485–508. doi: 10.1146/annurev.ph.56.030194.002413. [DOI] [PubMed] [Google Scholar]
  • 33.Fessenden JD, Wang Y, Moore RA, Chen SR, Allen PD, Pessah IN. Divergent functional properties of ryanodine receptor types 1 and 3 expressed in a myogenic cell line. Biophys J. 2000;79:2509–25. doi: 10.1016/S0006-3495(00)76492-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Bull R, Marengo JJ, Finkelstein JP, Behrens MI, Alvarez O. SH oxidation coordinates subunits of rat brain ryanodine receptor channels activated by calcium and ATP. Am J Physiol Cell Physiol. 2003;285:C119–28. doi: 10.1152/ajpcell.00296.2002. [DOI] [PubMed] [Google Scholar]

RESOURCES